Overview

Comparative Research of Alzheimer's Disease Drugs

Status:
Terminated

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

Conduct a comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care.

Phase:

N/A

Details

Lead Sponsor:

Indiana University

Collaborator:

Agency for Healthcare Research and Quality (AHRQ)

Treatments:

Donepezil
Galantamine
Rivastigmine